Dr. Petgrave is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 469-303-4200Fax+1 469-303-4225
Education & Training
- Baylor College of MedicineFellowship, Pediatric Nephrology, 2017 - 2020
- University of Miami/Jackson Health SystemResidency, Internal Medicine/Pediatrics, 2015 - 2019
- University of Miami/Jackson Health SystemResidency, Pediatrics, 2014 - 2017
- University of the West Indies Faculty of Medical SciencesClass of 2011
Certifications & Licensure
- TX State Medical License 2023 - 2025
- MS State Medical License 2020 - 2024
- TN State Medical License 2019 - 2024
- AR State Medical License 2020 - 2023
- PA State Medical License 2017 - 2018
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Nephrology
Publications & Presentations
PubMed
- 1 citationsSurgical correction of hydrothorax complicating pediatric peritoneal dialysisYonique Petgrave, Brittany L. Johnson, Shweta Shah, Paul K. Minifee, Sarah J. Swartz
Peritoneal Dialysis International. 2021-01-01 - 1 citationsAcute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent, and young adult patients with B-cell acute lymphoblastic leukemia.Yonique Petgrave, Subodh Selukar, Rebecca Epperly, Swati Naik, Noel DeLos Santos
Pediatric Nephrology. 2024-08-01 - Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent and young adult patients with B-cell acute lymphoblastic leukemia.Yonique P Petgrave, Subodh Selukar, Rebecca Epperly, Swati Naik, Noel DeLos Santos
Research Square. 2023-10-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: